GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein
2021 · Nature Communications · 121 citations
https://doi.org/10.1038/s41467-021-22297-8
M
Ming Zhao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
2.2K
Citations
19
h-index
24
i10-index
Ming Zhao is an academic researcher from National Center of Biomedical Analysis. The author has contributed to research in topics: interferon and immune responses & Cell death mechanisms and regulation & Cancer-related Molecular Pathways. The author has an h-index of 19, co-authored 34 publications.
ORCID: 0000-0002-7401-9332Papers by this author
worksLoss of PICH promotes chromosome instability and cell death in triple-negative breast cancer
2019 · Cell Death and Disease · 46 citations
https://doi.org/10.1038/s41419-019-1662-6
Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells
2018 · Scientific Reports · 24 citations
https://doi.org/10.1038/s41598-018-25284-0
Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice
2017 · Journal of Experimental & Clinical Cancer Research · 21 citations
https://doi.org/10.1186/s13046-017-0498-0
FGFR inhibitor, AZD4547, impedes the stemness of mammary epithelial cells in the premalignant tissues of MMTV-ErbB2 transgenic mice
2017 · Scientific Reports · 19 citations
https://doi.org/10.1038/s41598-017-11751-7
Targeting the liquid-liquid phase separation of nucleocapsid broadly inhibits the replication of SARS-CoV-2 strains
2025 · Biochemical and Biophysical Research Communications · 2 citations
https://doi.org/10.1016/j.bbrc.2025.151594
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat